Hyderabad: Srinivas Sadu, the incumbent Managing Director (MD) and CEO has been appointed as the Executive Chairman and CEO of Gland Pharma Limited. Effective June 10, 2024, Srinivas will take over the key responsibilities that align with the vision of the company.
With over 20 years of experience, Srinivas has been instrumental in the company’s growth and success since he assumed the role of MD and CEO on April 25, 2019. He began his career with the company in 2000. Sadu steadily rose through the ranks to become the Chief Operating Officer (CEO) in 2011.Â
Founded in Hyderabad, India, in 1978, Gland Pharma launched as a contract manufacturer of small-volume liquid parenteral products. The company has a global footprint in 60 countries including the US, Europe, Canada, Australia, India, and other markets.
